The researchers evaluated budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol in preventing COPD exacerbations and pneumonia hospitalizations in real-world settings.

Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Use of either fluticasone propionate or budesonide is suggested for patients with EoE treated with topical steroids. An ...

PEF = 100 l/min Budesonide 0.05 mg/kg × 1 (neb ... Effect produced by 880 µg of inhaled fluticasone on airway mucosal blood flow (Q aw) in ten asthmatic subjects and ten healthy subjects ...

Those receiving budesonide-glycopyrrolate-formoterol compared with fluticasone-umeclidinium-vilanterol had a higher risk for a first moderate COPD exacerbation (hazard ratio, 1.07; 95 percent ...

Both budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol provide the guideline-recommended combination of inhaled corticosteroid-long acting muscarinic antagonist (LAMA ...

Beclomethasone (QVAR): For adults and children ages 5 years and older. Generic budesonide suspension nebulizer: For children ages 1 year and older. Beclomethasone (QVAR) is as effective and ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...